Mello et al. [16], studying pancreatic cancer cells, found that PTPN14 suppressed the YAP activity that was necessary for p53 tumor suppressor function; a p53 transcriptional activation mutant showed elevated tumor suppression capacity because of hyperactivation of PTPN14. This evidence concerns the gene TP53 and pancreatic neoplasm.